North America Isotretinoin Drugs Market, By Country

Growth Outlook

• The North America Isotretinoin Drugs Market, By Country market is on a steady long-term growth path. Segment value stands at roughly USD 615 Mn in 2026 and is projected to reach USD 654 Mn by 2027 — a gain of about 6% over the forecast period, translating to a CAGR in the mid-single digits.
• The demand for isotretinoin drugs in North America varies significantly by country due to differences in healthcare systems, government policies and regulations, and patient needs. In this region, the United States, Canada, and Mexico are major consumers of these drugs.
• What the regional split looks like (2026): US leads, holding roughly 88% of segment value — the single largest regional share. Canada is the second-largest contributor.
• By 2027, US alone is expected to reach USD 572 Mn, with Canada at USD 81 Mn.

Market Dynamics

The demand for isotretinoin drugs in North America varies significantly by country due to differences in healthcare systems, government policies and regulations, and patient needs. In this region, the United States, Canada, and Mexico are major consumers of these drugs. The United States is the largest market for isotretinoin drugs in North America. This can be attributed to factors such as the high prevalence of acne, a large aging population, and a well-established healthcare system. In the U.S., isotretinoin drugs are primarily used for the treatment of severe and resistant cases of acne, as well as a variety of other skin conditions such as psoriasis and rosacea. The demand for these drugs in the U.S. is further driven by increasing awareness about the importance of skincare and the availability of these drugs through various distribution channels such as pharmacies and online retailers. Canada is another significant market for isotretinoin drugs in North America. The demand for these drugs in Canada is fueled by factors such as the rising prevalence of acne among young adults, a growing elderly population, and a favorable reimbursement system.

The Canadian healthcare system covers a significant portion of the cost of prescription drugs, making it more accessible and affordable for patients to obtain isotretinoin drugs. In Mexico, the demand for isotretinoin drugs is driven by the increasing prevalence of acne and the growing awareness about their benefits. Due to a lower overall healthcare expenditure compared to the U.S. and Canada, the demand for lower-priced generics of isotretinoin drugs is also higher in Mexico. However, the popularity of these drugs has also led to a rise in illegal and unregulated sales, which poses a threat to patient safety. The demand for isotretinoin drugs in North America is expected to continue to grow in the coming years as the population ages and the prevalence of dermatological conditions increases. Additionally, the introduction of newer formulations and combinations of isotretinoin drugs is likely to further drive demand in the region. In conclusion, while the demand for isotretinoin drugs is strong in North America as a whole, it may vary by country based on factors such as prevalence of skin conditions, healthcare systems, and government policies.

As the market continues to evolve, it will be important for pharmaceutical companies to understand these differences and tailor their marketing and distribution strategies accordingly to meet the demands of each country.

Research Methodology

Figures reflect Wantstats’ original market research and forecasting models, compiled as part of the Wantstats research archive and published in 2024.